Sort
130,381 grants matching “hiv”
Epidemiology and Natural History of Cancer-Associated Viruses
$1,617,068Sam M Mbulaiteye · Division Of Cancer Epidemiology And Genetics · ZIA · FY2023 · CA
A Cohort-Sequential Panal Study of Drug Use, Ages 19-50
$1,617,039Lloyd D Johnston · University Of Michigan At Ann Arbor · R01 · FY2011 · DA
NEW LIVE VIRAL VECTORS AS CANDIDATE AIDS VACCINES
$1,616,957Emory University · P01 · FY2002 · AI
NIMH Collaboration HIV/STD Intervention Trial in China
$1,616,830University Of California Los Angeles · U10 · FY2004 · MH
Center for Novel Therapeutics for HIV-Associated Cognitive Disorders
$1,616,710Justin C McArthur · Johns Hopkins University · P30 · FY2015 · MH
Modeling affinity maturation at molecular resolution
$1,616,696Thomas B Kepler · Boston University Medical Campus · U19 · FY2015 · AI
INCREASING ACCESS AND UTILIZATION OF HIV AND HEALTH SERVICES FOR REFUGEES
$1,616,303John W Burton · United Nation High Commissioner Refugees · U50 · FY2011 · CI
Simian Vaccine Evaluation Unit: Operation of a Nonhuman Primate Breeding Colony
$1,616,284Francois Villinger · University Of Louisiana At Lafayette · N01 · FY2020 · AI
Manipulating Epitope Immunodominance and Tracking B-cell-Antigen Interactions for Vaccine Design.
$1,616,010Amelia Escolano · Wistar Institute · DP2 · FY2022 · AI
Cold Chain-Independent, Needle-Free Mucosal Virosomal Vaccine to Prevent HIV-1 Acquisition at Mucosal Levels
$1,615,853Ruth Margrit Ruprecht · University Of Louisiana At Lafayette · U19 · FY2022 · AI
A practical microbicide based on HIV-1 entry inhibitors
$1,615,720John P Moore · Weill Medical Coll Of Cornell Univ · U19 · FY2010 · AI
A Cohort-Sequential Panal Study of Drug Use, Ages 19-50
$1,615,701Lloyd D Johnston · University Of Michigan At Ann Arbor · R01 · FY2009 · DA
Vanderbilt HIV Clinical Trials Unit
$1,615,311David W Haas · Vanderbilt University Medical Center · UM1 · FY2018 · AI
CTL and HIV Polymorphisms in Heterosexual Transmission
$1,615,187Eric Hunter · Emory University · R01 · FY2019 · AI
HIV Testing and Treatment to Prevent Onward HIV Transmission among High-risk MSM
$1,615,108Ann C Duerr · Fred Hutchinson Cancer Research Center · R01 · FY2011 · DA
Byramee Jeejeebhoy Medical College (BJMC), Pune, India: Clinical Trials Unit
$1,615,025Amita Gupta · Johns Hopkins University · UM1 · FY2013 · AI
Molecular Regulation Of RNA Metabolism
$1,614,991Richard J Maraia · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2011 · HD
Pathogenesis and Vaccine Studies Of Simian Immunodeficiency Virus Infection Of Monkeys
$1,614,805Vanessa M. Hirsch · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Comprehensive NeuroAIDS Core Center
$1,614,638Kamel Khalili · Temple Univ Of The Commonwealth · P30 · FY2014 · MH
Immunological Strategies to Modulate SIV Rebound Following ART Interruption
$1,614,482Michael R Betts · University Of Pennsylvania · P01 · FY2018 · AI
CNS & Peripheral Viral Reservoirs/SIV Model of HIV HAART
$1,614,436Janice Ellen Clements · Johns Hopkins University · P01 · FY2010 · MH
A Phase I Clinical Trial Testing Feasibility of Hematopoietic Stem Cell Gene Therapy Using Platelet Factor VIII to Safely Improve Hemostasis for Severe Hemophilia A with Inhibitory Antibodies
$1,613,689David Allen Wilcox · Medical College Of Wisconsin · R01 · FY2021 · HL
Antibody effector function in protection against HIV-1
$1,613,613Dennis R. Burton · Scripps Research Institute, The · R37 · FY2010 · AI
Bone Marrow Transplantation in Human Disease
$1,613,539Richard J Jones · Johns Hopkins University · P01 · FY2023 · CA
PS10-10133: INCREAS. ACC. TO QUAL. COMP. HIV PREVENTION SERVICES FOR MOST-AT-R
$1,613,090Lawrence Gelmon · University Of Manitoba · U2G · FY2014 · PS